Who should receive a 5-HT3 antagonist?
Kaye
S B
SB
Khayat
D
D
Aapro
M
M
Diehl
V
V
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000009:adverse effects; D017829:Granisetron; D006801:Humans; D007191:Indazoles / Q000627:therapeutic use*; D009325:Nausea / Q000517:prevention & control; D017294:Ondansetron / Q000627:therapeutic use*; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D014839:Vomiting / Q000517:prevention & control
D000970:Antineoplastic Agents; D017829:Granisetron; D007191:Indazoles; D017294:Ondansetron; D012702:Serotonin Antagonists